Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by SouthernTierTomon Nov 15, 2021 8:37am
119 Views
Post# 34126327

RE:So essentially our CMO Kellum has been with us....

RE:So essentially our CMO Kellum has been with us....17 out of 18 videos are publically available from the 39th Vicenza course in Italy.  3 of the 4 EDT involved videos are also publically available ( see the website under presentation )

Where is the "Keynote lecture" the all important #18 of 18 or in our spectral specific playlist #4 of 4?

Can we "selectively" share critical information and limit the dissemination of said "intel" to the owners of the company and the people paying the slary of the "keynote speaker"?

Do share, clearly it is part of the 10, 20 and 30 year plan of the firm ; - )

Dr. Kellum Invited to Participate on Additional Featured Panels

TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), are pleased to announce that Dr. John Kellum, the Company’s CMO, will be featured as the keynote lecturer at the virtual 39th Vicenza Course on Acute Kidney Injury (AKI) and Continuous Renal Replacement Therapy (CRRT) from Tuesday, October 26, 2021, to Friday, October 29, 2021. Dr. Kellum will discuss the importance of industry-academia collaboration in sepsis research:

Keynote Lecture: Industry and Academia: joining the forces in AKI and Sepsis
October 30, 2021, at 7:30 AM Eastern Time

Additionally, Dr. Kellum has been invited to participate in in the following featured panels:

Cappuccino with Claudio Ronco: CRRT Technology Update
Host: Dr. Claudio Ronco; Guest: Dr. John Kellum and SAMI
October 27, 2021, at 11:00 AM Eastern Time – Sponsored by Dialco Medical Inc.

Symposium: Endotoxic Shock: From Pathophysiology to Advanced Targeted Solutions
Moderator: Dr. Claudio Ronco; Speakers: Dr. John Kellum and Dr. Silvia De Rosa
October 27, 2021, at 12:15 PM Eastern Time – Sponsored by Estor S.p.A

Meet the Expert: Biomarkers (EAA) – Guided Initiation of PMX Hemoperfusion in Sepsis
Moderator: Dr. Claudio Ronco; Speaker: Dr. John Kellum
October 28, 2021, at 10:10 AM Eastern Time – Sponsored by Spectral Medical Inc.

<< Previous
Bullboard Posts
Next >>